18h
Hosted on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
23h
Hosted on MSNMillions missing out on key mineral that 'slashes Alzheimer's and Parkinson's risk'A nutritionist has said it's 'extremely worrying' that so many people are deficient in a mineral that can be easily obtained ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
23h
Futurism on MSNEvidence Is Growing That Ozempic Can Cause BlindnessAs drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
19h
US Weekly on MSNInfluencer Claudia Oshry Says She Used Ozempic ‘As a Tool to Change My Life’ Before PregnancyInfluencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.
Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as well as their implications for other applications like kidney disease and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results